Profound Medical PROF
NASDAQ PROF
$6.65 -0.43 (-6.07%)
At close: Aug 20, 2026 · 4:00 PM EDT

Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026)

Profound Medical (PROF) posted quarterly Asset Utilization Ratio of 0.25 for Q1 2026, up 33.6% year-over-year from 0.18 in Q1 2025, and down 7.06% quarter-over-quarter from 0.26 in Q4 2025.

Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Profound Medical's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.25 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 33.6% year-over-year to 0.25; the TTM figure through Mar 2026 stood at 0.25 (up 33.6% YoY), while the FY2025 annual figure was 0.22, up 16.53% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.25, down from 0.26 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.32 in Q3 2025, with the low at 0.18 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.42
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.55
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.39
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.47
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.48
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 0.76
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.57
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.80
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.56
10 Profound Medical 241.00 Mn 202.73 Mn 1.95 Mn 0.28

Historic Data

Download Data
DateValue
Jun 30, 2026 0.28
Mar 31, 2026 0.25
Dec 31, 2025 0.26
Sep 30, 2025 0.32
Jun 30, 2025 0.22
Mar 31, 2025 0.18